Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected Adults
Clinical trial NCT03505060 · WITHDRAWN
Trial details
- NCT number
- NCT03505060
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2019-05-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.